TickerFacts.

Revium Rx. (RVRC): Shareholders' Equity

Annual figures by period end, from SEC filings.

$6.88M
As of 2025-12-31
$5.52M
As of 2026-06-30
$19.71M2024-12-31: $19.71M2025-12-31: $6.88M$6.88M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$6.88M-65.1%2026-03-31, Balance as of period end
2024-12-31$19.71Mn/a2026-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Revium Rx. (RVRC)2025-12-31$6.88M-65.1%
Lunai Bioworks Inc. (LNAI)2025-06-30-$21.35Mn/m
Xenetic Biosciences, Inc. (XBIO)2025-12-31$7.40M+23.1%
GT Biopharma, Inc. (GTBP)2025-12-31$5.79Mn/a
CNS Pharmaceuticals, Inc. (CNSP)2025-12-31$4.52M-26.8%
GRI Bio, Inc. (GRI)2025-12-31$6.01M+49.0%
IGC Pharma, Inc. (IGC)2025-03-31$6.33M-13.5%
Dermata Therapeutics, Inc. (DRMA)2025-12-31$6.22M+298.7%
Processa Pharmaceuticals, Inc. (PCSA)2025-12-31$5.58M+228.8%

Compare RVRC, LNAI, XBIO, GTBP side by side · Screen every company in Pharmaceutical Preparations ↗